Pulmotect’s Positive Topline Results for Inhaled PUL-042 against COVID-19 Delivered by PARI Nebulizer
MIDLOTHIAN, Va - Pulmotect reported positive topline results from their randomized, placebo-controlled Phase-2 trial of PUL-042 against COVID-19. Patients treated with ...
